Skip to main content
. 2024 Apr 28;23(1):e145933. doi: 10.5812/ijpr-145933

Table 1. Comparison of General Information on Critically Ill Pediatrics Between the Two Groups of Intervention a.

Variables All Patients (n = 68, 100%) CIV (n = 33, 48.53%) IIV (n = 35, 51.47%) P-Value
General information
Age (mo) 38.96 ± 43.85 35.50 ± 41.75 42.22 ± 46.10 0.305
Age (y) 0.490
Younger than one year 26 (38.24) 14 (42.42) 12 (34.29)
Older than one year 42 (61.76) 19 (57.58) 23 (65.71)
Gender 0.038 b
Female 25 (36.76) 8 (24.24) 17 (48.57)
Male 43 (63.24) 25 (75.76) 18 (51.43)
Underlying diseases 0.190
CNS disease 11 (16.18) 6 (18.18) 5 (14.29)
Endocrine and metabolic syndrome 5 (7.35) 2 (6.06) 3 (8.57)
Gastrointestinal diseases 15 (22.06) 10 (30.30) 5 (14.29)
Blood disorders 5 (7.35) 0 (0.00) 5 (14.29)
Others 11 (16.18) 6 (18.18) 5 (14.29)
None 21 (30.88) 9 (27.27) 12 (34.29)
Chief complaint (yes) 0.079
Seizure 9 (13.24) 7 (21.21) 2 (5.71)
Loss of consciousness 4 (5.88) 4 (12.12) 0 (0.00) 0.050
Post-operation 22 (32.35) 12 (36.36) 10 (28.57) 0.492
Respiratory distress 34 (50.00) 11 (33.33) 23 (65.71) 0.008 b
Others c 10 (14.71) 5 (15.15) 5 (14.59) 0.920
Hospitalization and follow-up during treatment
Vital status
Alive discharged 47 (70.15) 20 (60.61) 27 (79.41) 0.093
Died 20 (29.85) 13 (39.39) 7 (20.59)
Mechanical ventilation (yes) 44 (64.71) 25 (75.76) 19 (54.29) 0.064
Ventilation time (day) 10.25 ± 8.46 10.26 ± 8.29 10.23 ± 8.87 0.755
Length of ICU stay (day) 22.30 ± 24.94 22.54 ± 14.10 22.17 ± 32.23 0.168
Length of hospital stay (day) 30.14 ± 30.76 27.63 ± 15.12 32.51 ± 40.46 0.457
Clinical characteristics
Height (cm) 88.54 ± 26.18 86.21 ± 24.30 90.74 ± 28.01 0.407
Weigh (kg) 13.19 ± 10.50 13.12 ± 11.77 13.25 ± 9.32 0.491
Pediatric Risk of Mortality (PRISM) score 6.91 ± 4.24 7.72 ± 4.09 6.14 ± 4.29 0.097

Abbreviations: CIV, continuous infusions of vancomycin; IIV, intermittent infusions of vancomycin; CNS, central nervous system; PRISM, pediatric risk of mortality.

a Values are expressed as No. (%) or mean ± SD.

b Statistically significant at P-value < 0.05.

c Such as respiratory, cardiovascular, musculoskeletal, or neuromuscular disorders.